509 related articles for article (PubMed ID: 25929574)
1. Nanomedicine for the treatment of Alzheimer's disease.
Gregori M; Masserini M; Mancini S
Nanomedicine (Lond); 2015; 10(7):1203-18. PubMed ID: 25929574
[TBL] [Abstract][Full Text] [Related]
2. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic compliance of nanomedicine in Alzheimer's disease.
Wilson B
Nanomedicine (Lond); 2011 Sep; 6(7):1137-9. PubMed ID: 21929451
[No Abstract] [Full Text] [Related]
4. Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
Gao N; Sun H; Dong K; Ren J; Qu X
Chemistry; 2015 Jan; 21(2):829-35. PubMed ID: 25376633
[TBL] [Abstract][Full Text] [Related]
5. [Role of the blood-brain barrier in Alzheimer's disease].
Gosselet F; Candela P; Cecchelli R; Fenart L
Med Sci (Paris); 2011 Nov; 27(11):987-92. PubMed ID: 22130026
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease.
Loureiro JA; Andrade S; Duarte A; Neves AR; Queiroz JF; Nunes C; Sevin E; Fenart L; Gosselet F; Coelho MA; Pereira MC
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208831
[TBL] [Abstract][Full Text] [Related]
7. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
Kino R; Araya T; Arai T; Sohma Y; Kanai M
Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
[TBL] [Abstract][Full Text] [Related]
8. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease.
Faustino C; Rijo P; Reis CP
Pharmacol Res; 2017 Jun; 120():68-87. PubMed ID: 28351757
[TBL] [Abstract][Full Text] [Related]
10. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
Zhang C; Zheng X; Wan X; Shao X; Liu Q; Zhang Z; Zhang Q
J Control Release; 2014 Oct; 192():317-24. PubMed ID: 25102404
[TBL] [Abstract][Full Text] [Related]
11. [The role of zinc ions and structural polymorphism of β-amyloid in the Alzheimer's disease initiation].
Kulikova AA; Makarov AA; Kozin SA
Mol Biol (Mosk); 2015; 49(2):249-63. PubMed ID: 26065253
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
[TBL] [Abstract][Full Text] [Related]
14. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease.
Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
Pharm Res; 2020 Jul; 37(7):139. PubMed ID: 32661727
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine for the Treatment of Alzheimer's Disease.
Formicola B; Cox A; Dal Magro R; Masserini M; Re F
J Biomed Nanotechnol; 2019 Oct; 15(10):1997-2024. PubMed ID: 31462368
[TBL] [Abstract][Full Text] [Related]
16. Graphene quantum dots for the inhibition of β amyloid aggregation.
Liu Y; Xu LP; Dai W; Dong H; Wen Y; Zhang X
Nanoscale; 2015 Dec; 7(45):19060-5. PubMed ID: 26515666
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
18. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer's Diseases.
Wang X; Ho SL; Poon CY; Yan T; Li HW; Wong MS
Curr Alzheimer Res; 2019; 16(9):836-842. PubMed ID: 31453789
[TBL] [Abstract][Full Text] [Related]
20. Peptide multifunctionalized gold nanorods decrease toxicity of β-amyloid peptide in a Caenorhabditis elegans model of Alzheimer's disease.
Morales-Zavala F; Arriagada H; Hassan N; Velasco C; Riveros A; Álvarez AR; Minniti AN; Rojas-Silva X; Muñoz LL; Vasquez R; Rodriguez K; Sanchez-Navarro M; Giralt E; Araya E; Aldunate R; Kogan MJ
Nanomedicine; 2017 Oct; 13(7):2341-2350. PubMed ID: 28673851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
